United States
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 12, 2010

OXiGENE, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of	0-21990 (Commission File Number)	13-3679168 (I.R.S. Employer Identification No.)
incorporation)

701 Gateway Boulevard, Suite 210, South San Francisco, CA 94080
(Address of principal executive offices)

Registrant’s telephone number, including area code: (650) 635-7000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:

o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

EXHIBITS

Ex-99.1 Press release dated August 12, 2010 reporting OXiGENE’s financial results for the second quarter ended June 30, 2010

     Item 2.02 Results of Operations and Financial Condition.

     On August 12, 2010 OXiGENE, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2010. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference. This information shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

     Item 9.01 Financial Statements and Exhibits.

     (c) The following exhibits are furnished with this report:

Exhibit Number	Description
99.1	Press release, dated August 12, 2010 reporting OXiGENE’s financial results for the second quarter ended June 30, 2010.

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	OXiGENE, Inc.
Date: August 12, 2010	/s/ Peter Langecker
	By: Peter J. Langecker
	Its: Chief Executive Officer

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press release, dated August 12, 2010 reporting OXiGENE’s financial results for the second quarter ended June 30, 2010.